There were 1,942 press releases posted in the last 24 hours and 347,770 in the last 365 days.
Detectives from the Metropolitan Police Department’s Homicide Branch are investigating a homicide that occurred on Saturday, January 7, 2023, in the 1000 block of Quincy Street, Northeast. At approximately 3:56 am, members of the Fifth District responded …
Detectives from the Metropolitan Police Department’s Homicide Branch are investigating a homicide that occurred on Saturday, January 7, 2023, in the 2000 block of Gallaudet Street, Northeast. At approximately 3:00 am, members of the Fifth District were …
STATE OF VERMONT DEPARTMENT OF PUBLIC SAFETY VERMONT STATE POLICE NEWS RELEASE MOTOR VEHICLE CRASH CASE#: 23A1000153 RANK/TROOPER FULL NAME: Trooper Blaz Mihaljevic STATION: Williston …
CALGARY, Alberta, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) is providing an update on its Downstream operations following recent extreme winter storms and severe cold temperatures at the company’s U.S. and Canadian …
Both vonoprazan 10 mg and 20 mg doses met the primary endpoint and showed highly statistically significant greater percentage of 24-hour heartburn free days as compared to placebo (p<0.0001) Data expected to provide the basis for future regulatory …
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Unisys Corporation (NYSE: UIS) between August 3, 2022 and November 7, 2022, both dates inclusive (the “Class Period …
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc - Transaction expands Chiesi's rare disease medicine portfolio - All cash acquisition at US$14.50 per ADS, plus Contingent Value Rights of up to an …
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR : Molecular Partners AG (MOLNMOLN, a clinical-stage biotech company developing a new class of custom-built protein drugs known …
VANCOUVER, Wash. and NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation ABSI, a generative AI drug creation company, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco …
Preliminary fourth quarter highlights: Expected total fourth quarter revenue, excluding COVID-19 testing, increased 28% compared to the fourth quarter 2021, with Screening revenue of $401.8-$402.8 million and Precision Oncology revenue of $142.9-$143.9 …
OTTAWA, ON, Jan. 8, 2023 /CNW/ - Defence Minister Anita Anand will hold a press conference to update Canadians on the Future Fighter Capability Project. This announcement will be preceded by an embargoed technical briefing, not for attribution, with senior …
ALISO VIEJO, Calif., Jan. 08, 2023 (GLOBE NEWSWIRE) -- RXST – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced certain preliminary unaudited financial and …
– Cabozantinib franchise achieves approximately $1.4 billion in preliminary U.S. net product revenues for full year 2022, including approximately $375 million for fourth quarter 2022 – – Full year 2023 net product revenues guidance of $1,575 million - $1, …
MARLBOROUGH, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. AKYA ("Akoya"), The Spatial Biology Company®, today announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2022. Akoya reported …
– Revenue of $1,074.2 Million Exceeds Guidance – – 15.8% Organic Constant Currency Growth in Diagnostics ex-COVID – – 24.5% Organic Constant Currency Growth in Molecular Diagnostics ex-COVID – – 14.7% Organic Constant Currency Growth in Surgical – Hologic, …
TORONTO, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Today marks three years since Ukraine International Airlines Flight PS752 was shot down by the Islamic Revolutionary Guard Corps (IRGC). The Association of Families of Flight PS752 Victims (the Association) …
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of The Gap, Inc. GPS between November 24, 2021 and July 11, 2022, both dates inclusive (the "Class Period"), …
– On track to fulfill all elements of Vision 3x3 to build a sustainable, profitable, leading biopharma company COPENHAGEN, Denmark, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S ASND today provided an update on its Vision 3x3 strategic roadmap …
Overall response rate (ORR) of 64% and clinical benefit rate (CBR) of 91% in 69 heavily-pretreated, RANO-evaluable patients Median duration of 8.4 months on therapy as of September 28, 2022, with 77% of patients remaining on treatment Additional data to be …
Cybin Inc. CYBN CYBN (Cybin or the Company), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics® today outlined its upcoming priorities and near-term milestones that support the development of its CYB003 and CYB004 clinical …
Don’t miss any breaking news!
Get the EIN Presswire App
Power your mobile with the latest breaking news by country, US state or industry.
